COPD Drugs Market in China 2016-2020

  • Published: Jun 2016
  • Pages: 75
  • SKU: IRTNTR9585

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

This market research study presents a comprehensive segmentation of the COPD drugs market in China by drug class and includes sub segments like bronchodilators, PDE-4 inhibitors, steroids, combination therapies, and other medications. Leading vendors in the market are AstraZeneca, Boehringer Ingelheim, GSK, Merck, and Novartis.

COPD drugs market forecast in China

According to the COPD drugs industry analysis, the chronic obstructive pulmonary disease (COPD) drugs market in China is envisaged to witness impressive growth and will post a CAGR of more than 15% over the forecast period. With the increasing population of smokers in the country, the market for COPD drugs in China will have a positive outlook in the coming years. Smoking leads to the damage of airways, air sacs, and the lining of the lungs, and triggers COPD flare-ups. China is the largest producer of tobacco in the world and accounts for nearly 42% of the world’s cigarette production. Also, the WHO has estimated that almost a third of the world’s smoking population is present in China. Moreover, factors like the improving economic conditions of the country have led individuals to smoke more cigarettes annually, which is anticipated to indirectly drive the COPD drugs market during the predicted period.

One of the emerging COPD drugs industry trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to treat COPD. Combination therapies are increasingly becoming the preferred choice of treatment as they have better efficacy than monotherapy drugs. Moreover, combination therapies reduce COPD-related hospitalizations and result in better treatment outcomes in patients. Therefore, it can be estimated that the increasing use of combinations therapies will increase the patient compliance toward the use of these respiratory drugs, which will, in turn, fuel this market’s growth prospects over the next four years.

COPD drugs market segmentation by drug class in China

  • Bronchodilators
  • PDE-4 inhibitors
  • Steroids
  • Combination therapies

The bronchodilators segment is one of the fastest growing segments of the COPD drugs market. Bronchodilators help relax bronchial muscles resulting in normal breathing. These drugs can be categorized into three types, namely beta-sympathomimetic, anticholinergics, and xanthine derivatives.

Competitive landscape and key vendors

Due to the presence of several small and large vendors, the COPD drugs market in China is highly competitive. The competitive environment is expected to intensify with the increase in product extensions, technological innovations, and an increase in the number of mergers and acquisitions.

 Key vendors in this market are 

  • AstraZeneca
  • Boehringer Ingelheim
  • GSK
  • Merck
  • Novartis

Other prominent vendors analyzed in this report are Ache Laboratorios Farmaceuticos, Almirall, Aquinox Pharmaceuticals, Ario Pharma, BioMarck Pharmaceuticals, Gilead Sciences, Mereo BioPharma Group, Mylan NV, Orion Corporation, Pearl Therapeutics, Prosonix, Teva Pharmaceutical, Theravance Biopharma, Theron Pharmaceuticals, Verona Pharma, Xention, and ZAI Lab.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the COPD drugs market in China?
  • What are the key market trends impacting the growth of the COPD drugs market in China?
  • What are the challenges to market growth?
  • Who are the key vendors in COPD drugs market in China?
  • What are the market opportunities and threats faced by the vendors in the COPD drugs market in China?
  • Trending factors influencing the market shares of China.
  • What are the key outcomes of the five forces analysis of COPD drugs market in China?

Technavio also offers customization on reports based on specific client requirement.

Related reports:

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of  the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: COPD: An overview

  • Causes and risk factors
  • Symptoms
  • Diagnosis
  • Management

PART 06: China-Country snapshot

  • Social and economic conditions
  • Healthcare reform
  • Healthcare infrastructure

PART 07: Pharmaceutical industry in China

  • Market overview
  • Major pharmaceutical vendors in China
  • Opportunities for global and local vendors
  • Drug approval process in China

PART 08: Drug pricing and reimbursement

  • Market-driven drug pricing strategy
  • Scrutinization of illegal pricing of drugs

PART 09: Pipeline portfolio

PART 10: Global respiratory drugs market

  • Market overview
  • Global COPD drugs market

PART 11: Market landscape

  • COPD drugs market in china
  • Five forces analysis

PART 12: Market segmentation by drug class

  • Bronchodilators
  • PDE-4 inhibitors
  • Steroids
  • Combination therapies
  • Other medications

PART 13: Market drivers

  • Increase in prevalence of smoking
  • Rise in healthcare expenditure
  • Increase in environmental pollution

PART 14: Impact of drivers

PART 15: Market challenges

  • Low diagnosis rate
  • Alternative therapies
  • High cost of therapy

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Rise in awareness programs
  • Increased focus on combination therapies
  • Rise in R&D by global companies

PART 18: Vendor landscape

  • Competitive scenario
  • AstraZeneca
  • Boehringer Ingelheim
  • GSK
  • Merck
  • Novartis
  • Other prominent vendors

PART 19: Appendix

  • List of abbreviations

PART 20: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO recognized

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted

  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>